How much revenue does Dhampur Bio Organics make?

Dhampur Bio Organics reported 18.62 billion INR in revenue for fiscal year 2025, down 0.2% from 18.64 billion INR in fiscal year 2024. In Q3 2026 revenue was 4.86 billion INR.

What is Dhampur Bio Organics's largest business segment?

Sugar, with 17.27 billion INR or 58% of segment revenue in fiscal year 2025. Next: Country Liquor (31%) and Bio Fuels & Spirits (11%).

Where does Dhampur Bio Organics make most of its revenue?

India: 99% of revenue by region in fiscal year 2025, followed by outside India (1%).

What companies are similar to Dhampur Bio Organics?

Listed companies of a similar size in the same industry (confection and treat manufacturing) include Prataap Snacks Limited (DIAMONDYD.NS), Avadh Sugar & Energy Limited (AVADHSUGAR.NS), Uttam Sugar Mills Limited (UTTAMSUGAR.NS), Dwarikesh Sugar Industries Limited (DWARKESH.NS).

Dhampur Bio Organics Limited (DBOL.NS) Stock

About Dhampur Bio Organics Limited

Dhampur Bio Organics Limited, together with its subsidiaries, manufactures and sells sugar in India and internationally. The company operates through three segments: Sugar; Biofuels and Spirits; and Country Liquor. It offers sulphurless sugar and sugar byproducts under the Dhampure brand name; ethanol and biogenic carbon dioxide; spirit and liquor; extra neutral alcohol; bagasse; and organic ferti...

At a glance

Dhampur Bio Organics reported revenue of 18.62 billion INR for fiscal year 2025, down 0.2% from fiscal year 2024, and net income of 146.90 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 4.86 billion INR, up 4.7% from a year before. Its largest business segment, Sugar, brought in 58% of segment revenue in fiscal year 2025; India was the largest region with 99%.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.